InvestSMART

Osteopore Limited (ASX:OSX)

ALERT: Price-sensitive ASX Announcement for OSX
Current share price for OSX : $0.004 -0.004 (-50%)+
Announcement
Release
12 Mar 2026 6:34PM
Price at Release
$0.008
Full Release
download
Summary
Osteopore Limited, a leading company in regenerative medicine, announced a clarification on their non-exclusive distribution agreement with DSM-Firmenich for their injectable regenerative bone filler in Southeast Asia. This partnership is aimed at capitalizing on a significant market opportunity within the Asia Pacific orthobiologics and bone graft substitutes market. Although the distribution agreement involves nominal fees and is not a significant financial commitment for Osteopore, the company expects meaningful revenue contributions if commercialisation and order quantities are successfully achieved. The product holds potential for substantial revenue generation contingent on successful registration and commercialization efforts.
Key Points
  • Osteopore Limited is a leader in 3D-printed biomimetic and bioresorbable implants.
  • Clarification on non-exclusive distribution agreement with DSM-Firmenich for Southeast Asia.
  • The agreement involves a nominal fee, representing approximately 1% of Osteopore's total assets at the end of FY25.
  • The market opportunity in Southeast Asia is valued between AUD 94.6M to AUD 284M.
  • Commercial success and meeting minimum order quantities are expected to contribute meaningfully to revenues.
  • Potential for the product to become a significant revenue stream with successful commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.